BDBM414009 US10421760, Comparative Example 10

SMILES C1CCC(=CC1)c1ncnc2[nH]ccc12

InChI Key InChIKey=FUSPDCUCMVYMCT-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 414009   

TargetTyrosine-protein kinase JAK3(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414009(US10421760, Comparative Example 10)
Affinity DataIC50: 125nMAssay Description:JAK3: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414009(US10421760, Comparative Example 10)
Affinity DataIC50: 166nMAssay Description:JAK 2: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414009(US10421760, Comparative Example 10)
Affinity DataIC50: 414nMAssay Description:JAK 1: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent